CTVA vs PROF · P/E 42, rev $16.91B vs rev $10.7M
Corteva Inc (CTVA) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
CTVA currently screens at market cap $51.52B and trailing P/E 41.6. PROF currently screens at market cap $238.7M.
Not investment advice. Open the CTVA and PROF stock pages for the full models.
Not investment advice.